The AAP diverges from CDC guidelines, advocating for Covid-19 vaccines in young children, igniting debate over vaccine policy ...

Rob Abbott, CEO, ISPOR, highlights how AI is streamlining research and improving patient care while stressing the importance of human oversight.

Why pharma and all stakeholders in the healthcare ecosystem should undertake a fundamental shift in how evidence to support ...

The disease doesn’t have any FDA approved treatments, leaving families desperate for FDA to approve the treatment.

Monument Therapeutics partners with FNIH to advance MT1988, a promising treatment for cognitive impairment in schizophrenia, ...

The global biotherapeutics company announced that it will seek to streamline operations as part of a broader transformation ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

A look back and ahead at the growing trend—sparked recently by the GLP-1 trail—and new ways to harness this Rx access channel ...

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...

Pharma can embrace product iteration over one-time launches—and enhance agility and responsiveness through effective roadmaps ...